000 01880 a2200553 4500
005 20250516065530.0
264 0 _c20120312
008 201203s 0 0 eng d
022 _a1465-3621
024 7 _a10.1093/jjco/hyr176
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShinohara, Nobuo
245 0 0 _aInterferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ.
_h[electronic resource]
260 _bJapanese journal of clinical oncology
_cFeb 2012
300 _a113-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma in Situ
_xdrug therapy
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCimetidine
_xadministration & dosage
650 0 4 _aDexamethasone
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aInterferon-alpha
_ximmunology
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMeloxicam
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
_xmethods
650 0 4 _aNephrectomy
650 0 4 _aThiazines
_xadministration & dosage
650 0 4 _aThiazoles
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aAbe, Takashige
700 1 _aSazawa, Ataru
700 1 _aMaruyama, Satoru
700 1 _aShindo, Junri
700 1 _aSato, Soshu
700 1 _aSuzuki, Shin
700 1 _aNonomura, Katsuya
773 0 _tJapanese journal of clinical oncology
_gvol. 42
_gno. 2
_gp. 113-9
856 4 0 _uhttps://doi.org/10.1093/jjco/hyr176
_zAvailable from publisher's website
999 _c21356882
_d21356882